Abivax Completes Recruitment of ABX464 Phase IIa HIV Study

Go back to Abivax Completes Recruitment of ABX464 Phase IIa HIV Study
(NASDAQ: ABVX) Delayed: 88.01 --0 (-0%)
Previous Close $88.01    52 Week High $ 
Open $88.01    52 Week Low $ 
Day High $88.01    P/E N/A 
Day Low $88.01    EPS $ 
Volume 3,293